Symptomatic Treatment of MS - European Multiple Sclerosis Platform
Symptomatic Treatment of MS - European Multiple Sclerosis Platform
Symptomatic Treatment of MS - European Multiple Sclerosis Platform
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
REFERENCES<br />
1. Abrams P, Amarenco G, Bakke A, and the <strong>European</strong> Tamsulosin Neurogenic Lower Urinary Tract<br />
Dysfunction Study Group (2003) Tamsulosin: efficacy and safety in patients with neurogenic<br />
lower urinary tract dysfunction due to suprasacral spinal cord injury. J Urol 170:1242-1251<br />
2. Agency for Health Care Policy and Research (1999) Diagnosis and treatment <strong>of</strong> swallowing disorders<br />
(dysphagia) in acute-care stroke patients. AHCPR Publication No 99-E024, Rockville, MD.<br />
www.ahcpr.gov/clinic/tp/dysphtp.htm<br />
3. Albrecht H, Schwecht M, Pöllmann W, Parag D, Erasmus LP, König N (1998) Local ice application in<br />
therapy <strong>of</strong> kinetic limb ataxia. Clinical assessment <strong>of</strong> positive treatment effects in patients with<br />
multiple sclerosis. Nervenarzt 69:1066-1073<br />
4. Alusi SH, Aziz TZ, Glickman S, Jahanshahi M, Stein JF, Bain PG (2001) Stereotactic lesional surgery<br />
for the treatment <strong>of</strong> tremor in multiple sclerosis: a prospective case-controlled study. Brain<br />
124:1576-1589<br />
5. Amato MP, Zipoli V, Portaccio E (2006) <strong>Multiple</strong> sclerosis-related cognitive changes: a review <strong>of</strong><br />
cross-sectional and longitudinal studies. J Neurol Sci 245: 41-46<br />
6. Attal N, Guirimand F, Brasseur L, Gaude V, Chauvin M, Bouhassira D (2002) Effects <strong>of</strong> IV morphine in<br />
central pain: a randomized placebo-controlled study. Neurology 58:554-563<br />
7. Averbuch-Heller L, Tusa RJ, Fuhry L, Rottach KG, Ganser GL, Heide W, Büttner U, Leigh RJ (1997) A<br />
double-blind controlled study <strong>of</strong> gabapentin and bacl<strong>of</strong>en as treatment for acquired nystagmus.<br />
Ann Neurol 41:818-825<br />
8. Backonja M (2003) Anticonvulsants for the treatment <strong>of</strong> neuropathic pain syndromes. Curr Pain<br />
Headache Rep 7:39-42<br />
9. Bandini F, Castello E, Mazzella L, Mancardi GL, Solaro C (2001) Gabapentin but not vigabatrin is<br />
effective in the treatment <strong>of</strong> acquired nystagmus in multiple sclerosis: How valid is the GABAergic<br />
hypothesis? J Neurol Neurosurg Psychiatry 71:107-110<br />
10. Banovac K, Wade N, Gonzalez F, Walsh B, Rhamy RK (1991) Decreased incidence <strong>of</strong> urinary tract<br />
infections in patients with spinal cord injury: effect <strong>of</strong> methenamine. J Am Paraplegia Soc 14:52-<br />
54<br />
11. Barak Y, Ur E, Achiron A (1999) Moclobemide treatment in multiple sclerosis patients with<br />
comorbid depression: an open-label safety trial. J Neuropsychiatry Clin Neurosci 11:271-273<br />
12. Barak Y, Achiron A (2002) Effect <strong>of</strong> interferon-beta-1b on cognitive functions in multiple sclerosis.<br />
Eur Neurol 47:11-14<br />
13. Bath PMW, Bath FJ, Smithhard DG (2000) Interventions for dysphagia in acute stroke. Cochrane<br />
Database Syst Rev. 2000;(2):CD000323.<br />
14. Beenakker EA, Oparina TI, Hartgring A, Teelken A, Arutjunyan AV, De Keyser J (2001) Cooling<br />
41 E<strong>MS</strong>P, <strong>Symptomatic</strong> <strong>Treatment</strong> <strong>of</strong> <strong>Multiple</strong> <strong>Sclerosis</strong>, December 2006 - revised in April 2008
Change language